Drug Topics
MARCH 29, 2025
Kari Franson, PharmD, PhD, BCPP, senior associate dean for academic and student affairs and professor of clinical pharmacy at the University of South Carolina, discusses the risk factors and considerations for cannabis use disorder.
Pharmacy Times
MARCH 29, 2025
Rivaroxaban offers more predictable dosing, eliminates frequent blood tests, and is less likely to interact with foods.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 29, 2025
Welcome to Lab Dish , a new First Opinion column on regenerative medicine from Paul Knoepfler. There are certain leaders who quietly make complex organizations operate well including in the toughest of times—leaders like Peter Marks, director of the Center for Biologics Evaluation and Research (CBER), who resigned Friday. Marks’ effectiveness at the Food and Drug Administration saved countless lives and greatly advanced the cell and gene therapy field.
Pharmacy Times
MARCH 29, 2025
Christian Ruff, MD, highlights abelacimabs potential to significantly reduce bleeding in patients with high-risk atrial fibrillation.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
MARCH 29, 2025
When Robert F. Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be the nation’s health secretary, the head of biotech’s largest trade group issued a statement saying that he had “every confidence” that the industry would “continue to thrive and deliver” on its goals, and looked forward to working closely with the new administration.
Pharmacy Times
MARCH 29, 2025
The availability of this option could make physicians more comfortable when prescribing ticagrelor, which could help solve the challenge of undertreatment with antiplatelet therapy.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MARCH 29, 2025
PD-L1 immune checkpoint inhibitors are now standard for early-stage non-metastatic non-small cell lung cancer (NSCLC), with neoadjuvant, adjuvant, and perioperative strategies improving survival and outcomes.
Pharmacy Times
MARCH 29, 2025
The DapaTAVI study is the first trial of a sodium-glucose cotransporter-2 (SGLT2) inhibitor for valvular disease.
Pharmacy Times
MARCH 29, 2025
The STRIDE trial was first of its kind to evaluate the use of a GLP-1 agonist in PAD management.
Expert insights. Personalized for you.
247 
Let's personalize your content